Pricing Log in Create free account

Corbus Pharmaceuticals Holdings, Inc. (CRBP) vs Promis Neurosciences (PMN)

Corbus Pharmaceuticals Holdings, Inc. and Promis Neurosciences are both Biotechnology companies. Corbus Pharmaceuticals Holdings, Inc. and Promis Neurosciences are of similar size ($83.8M and $78.0M). Promis Neurosciences grew revenue faster over the last twelve months: 450.0% against −73.7%. Across the 11 metrics below, Corbus Pharmaceuticals Holdings, Inc. leads on 7 and Promis Neurosciences on 4.

Valuation

Metric CRBP PMN Biotechnology median
P/E n/m n/m 8.50
P/S 56.97 33,868.44 9.71
P/B 0.86 1.51 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA 0.07 n/m 0.64
EV/Sales (5.25) 11,382.03 9.21
Earnings yield (136.95%) (155.70%) (33.15%)
Free cash flow yield (98.82%) (56.51%) (25.50%)

Profitability

Metric CRBP PMN Biotechnology median
Gross margin 0.00% 0.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (95.58%) (172.30%) (56.36%)
Return on assets (80.85%) (127.57%) (48.04%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric CRBP PMN Biotechnology median
Revenue growth (TTM) (73.69%) 450.00% 6.02%
EPS growth (last fiscal year) (60.33%) (922.18%) 30.26%
Revenue growth, 5-year CAGR (14.34%) — 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric CRBP PMN Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 5.71 7.85 4.72
Net debt to EBITDA 1.90 0.15 0.96

Dividend

Metric CRBP PMN Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric CRBP PMN Biotechnology median
Market cap 83.75m 78.02m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack